A recent systematic review and meta-analysis about safety of Ramadan fasting in type 1 diabetes [3] suggests that fine-tuning of insulin therapy by the use of pump infusion and intensive glucose control may mitigate hypoglycaemia risk. This evidence concerns the gene INS and type 1 diabetes mellitus.